Prime Medicine (PRME) PT Lowered to $7 at Stifel
Tweet
Share
E-mailGet Alerts PRME Hot Sheet
Price: $3.24 -8.47%
Rating Summary:
11 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
11 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Stifel analyst Dae Gon Ha lowered the price target on Prime Medicine (NASDAQ: PRME) to $7.00 (from $8.00) while maintaining a Hold rating.
You May Also Be Interested In
- BMO Capital Starts Prime Medicine (PRME) at Outperform
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Futu Holdings Limited (FUTU) PT Raised to $157 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
